Guatemala Healthcare Products
U.S. companies report ongoing challenges following the implementation of Guatemala’s new digital platform for sanitary registrations of medicines and related products. The system, introduced by the Ministerio de Salud Pública y Asistencia Social (MSPAS) as part of broader modernization efforts, aims to streamline the application and renewal processes and improve transparency. However, in practice, early-stage implementation issues are creating disruptions that affect regulatory timelines and market entry.
Stakeholders indicate that the platform has experienced technical instability, intermittent outages, and inconsistent processing of applications, limiting its effectiveness. Users also report a lack of clear guidance and insufficient training on the new system, contributing to errors in submissions and delays in approvals. As a result, companies face continued uncertainty regarding processing times for both new registrations and renewals.
Recent public reporting has also raised concerns regarding irregularities in the handling of sanitary registration processes, including the loss of files, potential manipulation of documentation, and select approvals granted in unusually short timeframes. While authorities have not yet clarified the full scope of these findings, such developments may further complicate the regulatory environment and reduce predictability for market participants.
Although the transition to a digital system is intended to improve efficiency, no clear timeline has been established for when the platform will operate consistently or how the ministry intends to resolve current deficiencies. In the interim, companies should anticipate continued bottlenecks and administrative challenges.
Given these conditions, U.S. exporters should plan for extended and less predictable registration timelines, maintain conservative product launch strategies, and engage closely with experienced local regulatory representatives. Early and thorough preparation of documentation remains critical, including Pharmaceutical Product Certificates, Good Manufacturing Practices (GMP) compliance evidence, and Central American Technical Regulations (RTCA)-aligned dossiers.
CS Guatemala is engaging with the ministry to provide private sector user feedback and discuss ways to address issues. For more information, please contact: Karla.Salas@trade.gov